Table 4 Lipid profile of adult patients on lipid-lowering treatment

Total cholesterol, mg/dL

(mmol/L)

326 ± 79

(8.4 ± 2.0)

225 ± 63^††

(5.8 ± 1.6)^††

392 ± 123

(10.1 ± 3.2)

215 ± 109^††

(5.6 ± 2.8)

Triglycerides, mg/dL

(mmol/L)

128 (94–179)

[1.4 (1.4–2.0)]

110 (80–154)^††

[1.2 (0.9–1.7)]^††

140 (99–192)

[1.6 (1.1–2.2)]

108 (75–153)^††

[1.2 (0.8–1.7)]^††

HDL-C, mg/dL

(mmol/L)

51 ± 14

(1.3 ± 0.4)

51 ± 15

(1.3 ± 0.4)

51 ± 13

(1.3 ± 0.3)

50 ± 14

(1.3 ± 0.3)

non-HDL-C, mg/dL

(mmol/L)

275 ± 79

(7.1 ± 2.0)

174 ± 63^††

(4.5 ± 1.6)^††

342 ± 119

(8.8 ± 3.1)

164 ± 106^††

(4.2 ± 2.7)^††

LDL-C_F, mg/dL

(mmol/L)

244 ± 68

(6.3 ± 1.8)

149 ± 59^††

(3.9 ± 1.5)^††

311 ± 118

(8.0 ± 3.1)

141 ± 103^††

(3.6 ± 2.7)^††

LDL-C_M/H, mg/dL

(mmol/L)

244 ± 68

(6.3 ± 1.8)

150 ± 59^††

(3.9 ± 1.5)^††

311 ± 118

(8.0 ± 3.1)

141 ± 102^††

(3.6 ± 2.6)^††

^aLDL-C_Lp(a)corM/H, mg/dL

(mmol/L)

243 ± 77

(6.3 ± 2.0)

118 ± 52^{†,§,††}

(3.1–1.3)^{†,§,††}

-^b

-^b

^aLp(a), mg/dL

(nmol/L)

25 (10–68)

[50.7 (18.0–144)]

26 (10–68)

[52.9 (18.0–144)]

-^b

-^b